5-Methylcytosine at HpaII sites in p53 is not hypermutable after UVC irradiation

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 431, Issue 1, 1999, Pages 93-103

  Monti, Paola ^a   Inga, Alberto ^a   Scott, Gina ^b   Aprile, Anna ^a   Campomenosi, Paola ^a   Menichini, Paola ^a   Ottaggio, Laura ^a   Viaggi, Silvia ^a,c   Abbondandolo, Angelo ^a,c   Burns, Philip A ^b   Fronza, Gilberto ^a  

^a Natl Cancer Inst (IST) Largo R   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

5 methylcytosine; Molecular epidemiology; p53; Ultraviolet light

Indexed keywords

5 METHYLCYTOSINE; CYTOSINE; PROTEIN P53;

ARTICLE; CONTROLLED STUDY; GENE MUTATION; METHYLATION; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; ULTRAVIOLET RADIATION;

5-METHYLCYTOSINE; CODON; CPG ISLANDS; CYTOSINE; DEOXYRIBONUCLEASE HPAII; DNA METHYLATION; HUMANS; MUTATION; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS; YEASTS;

EID: 0033388020     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00187-6     Document Type: Article

References (37)

1. Hainaut P., Hernandez T., Robinson A., Rodriguez-Tome P., Flores T., Hollstein M., Harris C.C., Montesano R. IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res. 26:1998;205-215.
2. Arrowsmith C.H., Morin P. New insights into p53 functions from structural studies. Oncogene. 12:1996;1379-1385.
3. Cho Y., Gorina S., Jeffrey P.D., Pavletich N.P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutation. Science. 265:1994;346-355.
4. Hann B.C., Lane D.P. The dominating effect of mutant p53. Nat. Genet. 9:1995;221-222.
5. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;823-831.
6. Harris C.C. The 1995 Walter Huber lecture - molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene. Br. J. Cancer. 73:1996;261-269.
7. Vogelstein B., Kinzler K.W. Carcinogens leave fingerprints. Nature. 355:1992;209-210.
8. Brash D.E., Rudolph J.A., Simon J.A., Lin A., McKenna G.J., Baden H.P., Halperin A.J., Ponten J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. U.S.A. 88:1991;10124-10128.
9. Ziegler A., Jonason A.S., Leffell D.J., Simon J.A., Sharma H.W., Kimmelman J., Remington L., Sacks T., Brash D.E. Sunburn and p53 in the onset of skin cancer. Nature. 372:1994;773-776.
10. Cariello N.F., Piegorsch W.W., Adams W.T., Skopek T.R. Computer programme for the analysis of mutational spectra: application to p53 mutations. Carcinogenesis. 15:1994;2281-2285.
11. Montesano R., Hainaut P., Wild C.P. Hepatocellular carcinoma: from gene to public health. J. Natl. Cancer Inst. 89:1997;1844-1851.
12. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer aetiology and molecular pathogenesis. Cancer Res. 54:1994;4855-4878.
13. Flaman J.M., Frebourg T., Moreau V., Charbonnier F., Martin C., Chappuis P., Sappino A.-P., Limacher J.-M., Bron L., Benhattar J., Tada M., van Meir E.G., Estreicher A., Iggo R. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc. Natl. Acad. Sci. U.S.A. 92:1995;3963-3967.
14. Inga A., Iannone R., Monti P., Molina F., Bolognesi M., Abbondandolo A., Iggo R., Fronza G. Determining mutational fingerprints at the human p53 locus with a yeast functional assay: a new tool for molecular epidemiology. Oncogene. 14:1997;1307-1313.
15. Inga A., Scott G., Monti P., Aprile A., Abbondandolo A., Burns P.A., Fronza G. Ultraviolet-light induced p53 mutational spectrum in yeast is indistinguishable from p53 mutations in human skin cancer. Carcinogenesis. 19:1998;741-746.
16. Moshinsky D., Wogan G.N. UV-induced mutagenesis of human p53 in a vector replicated in S. cerevisiae. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2266-2271.
17. Tornaletti S., Rozek D., Pfeifer G.P. The distribution of UV photoproducts along the human p53 gene and its relation to mutations in skin cancer. Oncogene. 8:1993;2051-2057.
18. Tornaletti S., Pfeifer G.P. Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene. 10:1995;1493-1499.
19. Magewu A.N., Jones P.A. Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as hot spot in cancer. Mol. Cell Biol. 14:1994;4225-4232.
20. Rideout W.M. III, Coetzee G.A., Olumi A.F., Jones P.A. 5-methylcytosine as an endogenous mutagen in the human LDL receptor and p53 gene. Science. 249:1990;1288-1290.
21. Fearon E.R., Jones P.A. Progressing toward a molecular description of colorectal cancer development. FASEB J. 6:1992;2783-2790.
22. Peng W., Shaw B.R. Accelerated deamination of cytosine residues in UV-induced cyclobutane dimers leads to CC>TT transitions. Biochemistry. 35:1996;10172-10181.
23. Bird A. The essential of DNA methylation. Cell. 70:1992;5-8.
24. Flaman J.M., Frebourg T., Moreau V., Charbonnier F., Martin C., Ishioka C., Friend F.S., Iggo R. A PCR fidelity assay. Nucleic Acid Res. 22:1994;3259-3260.
25. Miller J.H. Mutagenic specificity of ultraviolet light. J. Mol. Biol. 182:1985;45-68.
26. Bredberg A., Kraemer K.H., Seidman M.M. Restricted ultraviolet mutational spectrum in a shuttle vector propagated in Xeroderma pigmentosum cells. Proc. Natl. Acad. Sci. U.S.A. 83:1986;8273-8277.
27. Drobetsky E.A., Grovosky A.J., Glickman B.W. The specificity of UV-induced mutations at an endogenous locus in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 84:1987;9103-9107.
28. McGregor W.G., Chen R.H., Lubash L., Maher V.M., McCormick J.J. Cell cycle-dependent strand bias for UV-induced mutations in the transcribed strand of excision repair-proficient human fibroblasts but not in repair deficient cells. Mol. Cell. Biol. 11:1991;1927-1934.
29. Zuo S., Boorstein R.J., Cunningam R.P., Teebor G.W. Comparisons of the effects of UV irradiation on 5-methyl-substituted and unsubstituted pyrimidines in alternating pyrimidine-purine sequences in DNA. Biochemistry. 34:1995;11582-11590.
30. Zhang X., Mathews C.K. Effect of DNA Cytosine methylation upon deamination induced mutagenesis in a natural target sequence in duplex DNA. J. Biol. Chem. 269:1994;7066-7069.
31. Shen J.-C., Rideout W.M. III, Jones P.A. High frequency mutagenesis by a DNA methyltransferase. Cell. 71:1992;1073-1080.
32. Drouin R., Therrien J.-P. UVB-induced cyclobutane pyrimidine dimer frequency correlates with skin cancer mutational hotspots in p53. Photochem. Photobiol. 66:1997;719-726.
33. Tommasi S., Denissenko M.F., Pfeifer G.P. Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases. Cancer Res. 57:1997;4727-4730.
34. Tornaletti S., Pfeifer G.P. Slow repair of pyrimidine dimers at p53 mutation hotspot in skin cancer. Science. 263:1994;1436-1438.
35. Douki T., Cadet J. Formation of cyclobutane dimers and (6-4) photoproducts upon far-UV photolysis of 5-Methylcytosine-containing dinucleotide monophosphate. Biochemistry. 33:1994;11942-11950.
36. Lemaire D.G., Ruzsicska B.P. Kinetic analysis of the deamination reactions of cyclobutane dimers of thymidylyl-3′,5′-2′-deoxycytidine and 2′deoxycytidylyl-3′,5′-thymidine. Biochemistry. 32:1993;2525-2533.
37. Denissenko M.F., Chen J.X., Tang M.S., Pfeifer G.P. Cytosine methylation determines hotspots of DNA damage in the human p53 gene. Proc. Natl. Acad. Sci. U.S.A. 94:1997;3893-3898.